Meihua International Medical Technologies Co., Ltd. (MHUA)
USD 0.27
(-44.94%)
USD 0.27
(-44.94%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.61 Million USD | 44.13% |
| 2022 | 1.12 Million USD | -10.34% |
| 2021 | 1.25 Million USD | -5.63% |
| 2020 | 1.32 Million USD | 29.38% |
| 2019 | 1.02 Million USD | -44.43% |
| 2018 | 1.84 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 1.09 Million USD | 0.0% |
| 2024 Q1 | 1.09 Million USD | -32.46% |
| 2023 Q4 | 1.61 Million USD | 0.0% |
| 2023 Q1 | 1.64 Million USD | 46.8% |
| 2023 FY | 1.61 Million USD | 44.13% |
| 2023 Q3 | 1.61 Million USD | -1.82% |
| 2023 Q2 | 1.64 Million USD | 0.0% |
| 2022 Q4 | 1.12 Million USD | 0.0% |
| 2022 Q3 | 1.12 Million USD | -6.3% |
| 2022 FY | 1.12 Million USD | -10.34% |
| 2022 Q2 | 1.19 Million USD | 0.0% |
| 2022 Q1 | 1.19 Million USD | -4.3% |
| 2021 Q1 | 1.3 Million USD | -1.79% |
| 2021 FY | 1.25 Million USD | -5.63% |
| 2021 Q4 | 1.25 Million USD | 0.0% |
| 2021 Q2 | 1.3 Million USD | 0.0% |
| 2021 Q3 | 1.25 Million USD | -3.92% |
| 2020 Q3 | 1.32 Million USD | -25.68% |
| 2020 Q4 | 1.32 Million USD | 0.0% |
| 2020 Q2 | 1.78 Million USD | 0.0% |
| 2020 Q1 | 1.78 Million USD | 74.09% |
| 2020 FY | 1.32 Million USD | 29.38% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | 1.02 Million USD | -44.43% |
| 2019 Q4 | 1.02 Million USD | 0.0% |
| 2019 Q3 | 1.02 Million USD | 0.0% |
| 2018 FY | 1.84 Million USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 17.87 Million USD | 90.954% |
| AngioDynamics, Inc. | 60.61 Million USD | 97.332% |
| AtriCure, Inc. | 67.89 Million USD | 97.618% |
| Avinger, Inc. | 5.29 Million USD | 69.475% |
| Azenta, Inc. | 128.19 Million USD | 98.738% |
| BioLife Solutions, Inc. | 43.45 Million USD | 96.278% |
| The Cooper Companies, Inc. | 735.6 Million USD | 99.78% |
| Daxor Corporation | - USD | -Infinity% |
| Ekso Bionics Holdings, Inc. | 5.05 Million USD | 67.976% |
| Femasys Inc. | 667.11 Thousand USD | -142.42% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 24.71 Million USD | 93.457% |
| Hologic, Inc. | 679.8 Million USD | 99.762% |
| ICU Medical, Inc. | 709.36 Million USD | 99.772% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 99.868% |
| KORU Medical Systems, Inc. | 3.48 Million USD | 53.545% |
| LeMaitre Vascular, Inc. | 52.33 Million USD | 96.91% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -88.761% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -88.761% |
| Masimo Corporation | 545 Million USD | 99.703% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Merit Medical Systems, Inc. | 303.87 Million USD | 99.468% |
| Nephros, Inc. | 2.47 Million USD | 34.525% |
| NovoCure Limited | 38.15 Million USD | 95.761% |
| NEXGEL, Inc. | 1.31 Million USD | -22.61% |
| NEXGEL, Inc. | 1.31 Million USD | -22.61% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | 88.084% |
| OraSure Technologies, Inc. | 47.61 Million USD | 96.603% |
| Pro-Dex, Inc. | 15.26 Million USD | 89.408% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -227.126% |
| Precision Optics Corporation, Inc. | 2.86 Million USD | 43.613% |
| QuidelOrtho Corporation | 577.8 Million USD | 99.72% |
| Repligen Corporation | 202.32 Million USD | 99.201% |
| Sanara MedTech Inc. | 4.71 Million USD | 65.719% |
| STAAR Surgical Company | 35.13 Million USD | 95.396% |
| Sharps Technology, Inc. | 1.7 Million USD | 5.378% |
| Utah Medical Products, Inc. | 9.58 Million USD | 83.122% |
| DENTSPLY SIRONA Inc. | 624 Million USD | 99.741% |
| Jin Medical International Ltd. | 5.05 Million USD | 67.996% |